Cellcura ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA Announced Subsequent Offering
Cellcura ASA announced that following the private placement of 41,697,843 new shares, the Company has decided to conduct a subsequent offering of up to 125,000,000 offer shares at a price of NOK 0.20 per share. The offer shares may be subscribed for by shareholders that owned shares in the company as of June 13, 2013 and who did not participated in the private placement. The subscription period runs from August 14, 2013 to August 30, 2013 at 16:30 (CET). Allocation rights not used to subscribe for Offer Shares before the expiry of the subscription period will be of no value and will lapse without compensation to the holder.
Latest Developments for Cellcura ASA
Latest Key Developments in Medical
- IDEXX Laboratories Inc raises FY 2014 revenue outlook; reaffirms FY 2014 EPS outlook
- Ocular Therapeutix Inc prices initial public offering
- C R Bard Inc gives Q3 2014 guidance; EPS guidance in line with analysts' estimates; raises FY 2014 EPS guidance; gives FY 2014 revenue guidance above analysts' estimates - Conference Call
- Uroplasty Inc reaffirms FY 2015 guidance - Conference Call
- Share this
- Digg this